Effects of taxifolin on tramadol-induced oxidative and inflammatory liver injury in rats: an experimental study

ArticleAçık Erişim

Özet

In this experimental study we aimed to investigate the biochemical and histopathological effects of concomitantly administered taxifolin on tramadol-induced liver damage in rats. The rats were divided into three groups; control group (CG), tramadol alone (TRG), and taxifolin + tramadol given (TTRG) groups. Malondialdehyde (MDA), total glutathione (tGSH), total oxidant status (TOS), total antioxidant status (TAS), nuclear factor-kappa beta (NF-kB), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) levels were measured in liver tissues. Liver tissues were also examined histopathologically. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were determined in blood samples. In tissue analyses, determinants of oxidative stress and inflammation, all were significantly higher in the TRG group compared with the control and TTRG groups. In the TTRG group, all oxidative stress and inflammation markers were significantly lower than in the TRG group. In addition, there was not any significant difference between the control and TTRG groups regarding the TOS and TAS status. Serum liver enzymes were also significantly higher in the TRG group than in the other two groups. In histopathological examinations, the control group had a normal histological appearance. Degenerative-necrotic hepatocytes and hemorrhage, which were seen at a severe level in the TRG group, were found to be moderate in the treated TTRG group. In addition, mononuclear cell infiltrations were found to be severe in the TRG group and mild in the treated TTRG group. Finally it was concluded that Taxifolin alleviated the toxic effects of tramadol on the liver including the histopathological and biochemical changes as well as the oxidative damage. © 2023 Informa UK Limited, trading as Taylor & Francis Group.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11618Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÖlmeztürk Karakurt, Tülay Ceren
dc.contributor.authorEren, Nurhan
dc.contributor.authorSubaşı, Faruk
dc.contributor.authorKuyrukluyıldız, Ufuk
dc.contributor.authorÇoban, Taha Abdulkadir
dc.contributor.authorSüleyman, Halis
dc.contributor.authorMokhtare, Behzad
dc.date.accessioned2026-10-18T20:26:38.587669581Z
dc.date.available2026-10-18T20:26:38.587669581Z
dc.date.issued2024
dc.description.abstractIn this experimental study we aimed to investigate the biochemical and histopathological effects of concomitantly administered taxifolin on tramadol-induced liver damage in rats. The rats were divided into three groups; control group (CG), tramadol alone (TRG), and taxifolin + tramadol given (TTRG) groups. Malondialdehyde (MDA), total glutathione (tGSH), total oxidant status (TOS), total antioxidant status (TAS), nuclear factor-kappa beta (NF-kB), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) levels were measured in liver tissues. Liver tissues were also examined histopathologically. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were determined in blood samples. In tissue analyses, determinants of oxidative stress and inflammation, all were significantly higher in the TRG group compared with the control and TTRG groups. In the TTRG group, all oxidative stress and inflammation markers were significantly lower than in the TRG group. In addition, there was not any significant difference between the control and TTRG groups regarding the TOS and TAS status. Serum liver enzymes were also significantly higher in the TRG group than in the other two groups. In histopathological examinations, the control group had a normal histological appearance. Degenerative-necrotic hepatocytes and hemorrhage, which were seen at a severe level in the TRG group, were found to be moderate in the treated TTRG group. In addition, mononuclear cell infiltrations were found to be severe in the TRG group and mild in the treated TTRG group. Finally it was concluded that Taxifolin alleviated the toxic effects of tramadol on the liver including the histopathological and biochemical changes as well as the oxidative damage. © 2023 Informa UK Limited, trading as Taylor & Francis Group.
dc.identifier.doi10.1080/01480545.2023.2199175
dc.identifier.eissn1525-6014
dc.identifier.endpage462
dc.identifier.issn0148-0545
dc.identifier.issue4
dc.identifier.pmid37042292
dc.identifier.scopus2-s2.0-85152407657
dc.identifier.startpage457
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11618
dc.identifier.volume47
dc.identifier.wosWOS:000970672400001
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofDrug and Chemical Toxicology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnalgesia
dc.subjectdrug-induced liver injury
dc.subjectflavonoid
dc.subjectglutathione
dc.subjectmalondialdehyde
dc.subjectoxidative stress
dc.subjecttramadol
dc.subjectAlanine Transaminase
dc.subjectAnalgesics, Opioid
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectAspartate Aminotransferases
dc.subjectChemical and Drug Induced Liver Injury
dc.subjectInflammation
dc.subjectInterleukin-1beta
dc.subjectLiver
dc.subjectMale
dc.subjectNF-kappa B
dc.subjectQuercetin
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectTumor Necrosis Factor-alpha
dc.subjectalanine aminotransferase
dc.subjectaspartate aminotransferase
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectinterleukin 1beta
dc.subjectliver enzyme
dc.subjectmalonaldehyde
dc.subjecttaxifolin
dc.subjectthiopental
dc.titleEffects of taxifolin on tramadol-induced oxidative and inflammatory liver injury in rats: an experimental study
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.citation.wos3
rdl.departmentAnesthesiology and Reanimation Clinic, Erzincan Binali Yıldırım University, Mengücek Gazi Training and Research Hospital, Erzincan, Turkey. | Department of Anesthesiology and Reanimation, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Clinical Biochemistry, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)